Patel Samir Rashmikant bought AKTX
July 7, 2026 · Form 4 insider transaction
Patel Samir Rashmikant bought 5,799 shares of Akari Therapeutics, Plc at $0.00 per share, a transaction worth $2.32. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 10 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,799
Price
$0.00
Total value
$2.32
InsiderPatel Samir Rashmikant
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeM: Option exercise
Transaction dateJuly 7, 2026
Filing dateJuly 17, 2026
Shares owned after98,241
OwnershipIndirect
10b5-1 planNo
AmendedNo